Bcwm LLC Takes Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Bcwm LLC bought a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 44,071 shares of the exchange traded fund’s stock, valued at approximately $3,969,000.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Mirae Asset Securities USA Inc. boosted its position in shares of SPDR S&P Biotech ETF by 66.7% in the 4th quarter. Mirae Asset Securities USA Inc. now owns 1,500,000 shares of the exchange traded fund’s stock valued at $135,090,000 after purchasing an additional 600,000 shares during the period. Proficio Capital Partners LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 16,156.1% in the fourth quarter. Proficio Capital Partners LLC now owns 917,329 shares of the exchange traded fund’s stock worth $82,615,000 after buying an additional 911,686 shares during the period. Raymond James Financial Inc. purchased a new position in shares of SPDR S&P Biotech ETF in the fourth quarter worth approximately $55,529,000. Whittier Trust Co. raised its holdings in shares of SPDR S&P Biotech ETF by 3.1% during the fourth quarter. Whittier Trust Co. now owns 320,740 shares of the exchange traded fund’s stock valued at $28,885,000 after acquiring an additional 9,713 shares during the period. Finally, J.Safra Asset Management Corp lifted its position in shares of SPDR S&P Biotech ETF by 461.6% in the 4th quarter. J.Safra Asset Management Corp now owns 292,502 shares of the exchange traded fund’s stock valued at $26,293,000 after acquiring an additional 240,415 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

SPDR S&P Biotech ETF stock opened at $84.40 on Friday. SPDR S&P Biotech ETF has a 52 week low of $81.14 and a 52 week high of $105.47. The firm has a market capitalization of $5.47 billion, a price-to-earnings ratio of 11.47 and a beta of 0.99. The company has a 50 day moving average price of $89.40 and a 200 day moving average price of $93.94.

SPDR S&P Biotech ETF Cuts Dividend

The firm also recently declared a dividend, which was paid on Wednesday, March 26th. Stockholders of record on Monday, March 24th were issued a dividend of $0.0053 per share. The ex-dividend date of this dividend was Monday, March 24th.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.